In this issue:
Weight loss before CAR T-cell therapy
Siltuximab for CRS and ICANS
Addition of nivolumab to CAR-T cells
GPC3 CAR-T cells co-expressing IL-15
Tolerability of IV autologous GD2-CAR T cells
Efficacy of CD5-gene-edited CAR-T cell therapy
TRBC1-directed autologous CAR-T cells
Occurrence of late AEs
Impact of broad-spectrum antibiotics
Survival outcomes of DHL and DEL DLBCL
Please login below to download this issue (PDF)